V-9-M Cholecystokinin nonapeptide

CAS No. 99291-20-0

V-9-M Cholecystokinin nonapeptide( —— )

Catalog No. M37925 CAS No. 99291-20-0

V-9-M Cholecystokinin nonapeptide (Prepro CCK Fragment V-9-M) is a precursor compound of cholecystokinin (CCK).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 59 In Stock
5MG 76 In Stock
10MG 116 In Stock
25MG 181 In Stock
50MG 273 In Stock
100MG 408 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    V-9-M Cholecystokinin nonapeptide
  • Note
    Research use only, not for human use.
  • Brief Description
    V-9-M Cholecystokinin nonapeptide (Prepro CCK Fragment V-9-M) is a precursor compound of cholecystokinin (CCK).
  • Description
    Cholecystokinin Precursor (24-32) (rat) is a cholecystokinin precursor that can be expressed in the heart, lungs, and kidneys as well as in the gastrointestinal tract and brain. Cholecystokinin is a brain-gut peptide that stimulates gallbladder contraction and pancreatic exocrine secretion and also acts as a neurotransmitter.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Beta Amyloid
  • Recptor
    Beta Amyloid
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    99291-20-0
  • Formula Weight
    956.11
  • Molecular Formula
    C42H69N9O14S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (104.59 mM; Ultrasonic )
  • SMILES
    C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(=O)[C@H]1N(C([C@H](C(C)C)N)=O)CCC1)[C@H](C)C)=O)CCC(O)=O)=O)C)=O)C(C)C)=O)CC(O)=O)(=O)N2[C@H](C(N[C@@H](CCSC)C(O)=O)=O)CCC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. A Funakoshi, et al. Expression of the cholecystokinin precursor gene in rat tissues. J Gastroenterol. 1994 Apr;29(2):125-8.?
molnova catalog
related products
  • Trontinemab

    Trontinemab (RG6102) is a human IgG1-κ antibody selectively targeting Aβ precursor protein (APP) with transferrin receptor p90, CD71 (TFRC), inhibits amyloid production, and can be used to study neurological disorders such as Alzheimer's disease.

  • Fenlean

    Fenlean (FLZ) is a tyrosine kinase Src inhibitor, a synthetic cyclic derivative of squamous amide from Annona glabra, with cytoprotective activity, which protects tyrosine hydroxylase function in a chronic MPTP/prostaglandin-type mouse model of Parkinson's disease.

  • β-Amyloid 1-28

    β-Amyloid (1-28) is a β-Amyloid protein fragment involved in metal binding.